Clinical Outcomes of MLC601 (NeuroAiDTM) in Traumatic Brain Injury: A Pilot Study

• Main Authors: Asra Al Fauzi, Asra, Krisna Tsaniadi Prihastomo, Krisna, I. G. M. Aswin R. Ranuh, Aswin, Tedy Apriawan, Tedy, Joni Wahyuhadi, Joni, M. Arifin Parenrengi, Arifin, Agus Turchan, Agus, Abdul Hafid Bajamal, Abdul, Hari Basuki Notobroto, Hari
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Multidisciplinary Digital Publishing Institute (MDPI)
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/120043/1/12.%20Artikel__compressed.pdf; https://repository.unair.ac.id/120043/2/12.%20turnitin.pdf; https://repository.unair.ac.id/120043/6/12.%20karil.pdf; https://repository.unair.ac.id/120043/; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071378/
• Institution: Universitas Airlangga

Abstract Background: MLC601 is a natural product formulation from Chinese medicine that is extensively studied in ischemic stroke. Traumatic brain injury (TBI) shares pathophysiological mechanisms with ischemic stroke, yet there are few studies on the use of MLC601 in treating TBI. This Indonesian...